- Profile
- prev
- next
General
-
Headquarters
Carlsbad, California 92008, United States
-
Founders & Team
Judith Segall, Michael D West, Paul Segall, William P. Tew, Brian M. Culley, Oscar Cuzzani
-
Year Founded
1990
-
Number of employees
200
-
Company type
Private company
-
Stock Ticker
NYSE:LCTX
-
Total funding ($M)
108.8
-
Investors
Hadasit Bio-Holdings, OncoCyte Corporation
Technical Details
-
Aging Target
Cell Loss
-
Disease indication
Dry AMD, spinal cord injury
-
Product modality
cell therapy
-
Clinical stage
Phase 2 Trials
About
Lineage Cell Therapeutics is a clinical-stage biotechnology company developing novel cellular therapies to treat unmet medical needs.
Lineage’s programs are based on the Company’s proprietary cell-based therapy platform and associated development and manufacturing capabilities. With our platform we develop and manufacture specialized, terminally-differentiated human cells from our pluripotent and progenitor cell starting materials. These differentiated cells are developed either to replace or support cells that are dysfunctional or absent due to degenerative disease or traumatic injury, or administered as a means of helping the body mount an effective immune response to cancer.